Lucy Pérez and Shubham Singhal
Lucy Pérez is a senior partner in McKinsey & Company’s Boston office. A former cancer researcher, Lucy brings a strong technical background to her work with organizations across the life-sciences sector. Since joining McKinsey, she has partnered with CEOs and top teams at leading organizations across North America, Europe, and Asia. She leads evidence-generation work within the Life Sciences Practice, helping clients generate and apply research insights, clinical data, and real-world evidence to maximize patient benefit, demonstrate product value, and catalyze innovation. In addition to her client service, Lucy coleads the North America Hispanic Latino Network, a platform for consultants and Hispanic and Latino leaders to connect and build community as well as advance their professional development. Before joining McKinsey, Lucy was a research fellow at Memorial Sloan Kettering Cancer Center. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies.
Shubham Singhal is a senior partner in Detroit. Shubham leads McKinsey’s healthcare, public sector and social sector work globally. He serves leading healthcare and social institutions and governments on all top-management agenda issues. His primary areas of focus include strategy, growth, M&A, business building, and large-scale digital and performance transformations. In healthcare, he has extensively served publicly traded and not-for-profit payers as well as public payers for more than 20 years. He also serves providers as well as healthcare technology and pharmacy companies. Shubham also leads the firm’s thinking and research on the future of healthcare in the wake of rapid advancements in digital, advanced analytics, and medical technologies; emergence of new treatments; healthcare reform and regulatory change; the rise of the healthcare consumer; and risk disaggregation and reallocation across the healthcare system.
-
MedCity Influencers, Health Tech
Women’s health needs have been overlooked. Can “FemTech” fill the gap?
By Lucy Pérez and Shubham Singhal
Funding in FemTech startups has risen from next to nothing in 2008, to almost $2.5 billion in 2021; deals have seen the same trend, from a handful to almost 300 over the same period.
Share/ Jul 27, 2022 at 9:00 AM
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
MedCity >> Inbox
Get the latest industry news first when you subscribe to our newsletter.
We will never sell or share your information without your consent. See our privacy policy.Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.